These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

651 related articles for article (PubMed ID: 7679413)

  • 1. Binding of myelin basic protein peptides to human histocompatibility leukocyte antigen class II molecules and their recognition by T cells from multiple sclerosis patients.
    Valli A; Sette A; Kappos L; Oseroff C; Sidney J; Miescher G; Hochberger M; Albert ED; Adorini L
    J Clin Invest; 1993 Feb; 91(2):616-28. PubMed ID: 7679413
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Myelin basic protein-specific T lymphocyte repertoire in multiple sclerosis. Complexity of the response and dominance of nested epitopes due to recruitment of multiple T cell clones.
    Meinl E; Weber F; Drexler K; Morelle C; Ott M; Saruhan-Direskeneli G; Goebels N; Ertl B; Jechart G; Giegerich G
    J Clin Invest; 1993 Dec; 92(6):2633-43. PubMed ID: 7504690
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Fine specificity and HLA restriction of myelin basic protein-specific cytotoxic T cell lines from multiple sclerosis patients and healthy individuals.
    Martin R; Jaraquemada D; Flerlage M; Richert J; Whitaker J; Long EO; McFarlin DE; McFarland HF
    J Immunol; 1990 Jul; 145(2):540-8. PubMed ID: 1694881
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Response of human T lymphocyte lines to myelin basic protein: association of dominant epitopes with HLA class II restriction molecules.
    Chou YK; Vainiene M; Whitham R; Bourdette D; Chou CH; Hashim G; Offner H; Vandenbark AA
    J Neurosci Res; 1989 Jun; 23(2):207-16. PubMed ID: 2474079
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Blood CD8+ T cell responses against myelin determinants in multiple sclerosis and healthy individuals.
    Berthelot L; Laplaud DA; Pettré S; Ballet C; Michel L; Hillion S; Braudeau C; Connan F; Lefrère F; Wiertlewski S; Guillet JG; Brouard S; Choppin J; Soulillou JP
    Eur J Immunol; 2008 Jul; 38(7):1889-99. PubMed ID: 18506883
    [TBL] [Abstract][Full Text] [Related]  

  • 6. T-cell recognition of an immunodominant myelin basic protein epitope in multiple sclerosis.
    Ota K; Matsui M; Milford EL; Mackin GA; Weiner HL; Hafler DA
    Nature; 1990 Jul; 346(6280):183-7. PubMed ID: 1694970
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Diversity in fine specificity and T cell receptor usage of the human CD4+ cytotoxic T cell response specific for the immunodominant myelin basic protein peptide 87-106.
    Martin R; Utz U; Coligan JE; Richert JR; Flerlage M; Robinson E; Stone R; Biddison WE; McFarlin DE; McFarland HF
    J Immunol; 1992 Mar; 148(5):1359-66. PubMed ID: 1371525
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Predominant and stable T cell responses to regions of myelin basic protein can be detected in individual patients with multiple sclerosis.
    Salvetti M; Ristori G; D'Amato M; Buttinelli C; Falcone M; Fieschi C; Wekerle H; Pozzilli C
    Eur J Immunol; 1993 Jun; 23(6):1232-9. PubMed ID: 7684682
    [TBL] [Abstract][Full Text] [Related]  

  • 9. HLA-DRB1*1501 risk association in multiple sclerosis may not be related to presentation of myelin epitopes.
    Finn TP; Jones RE; Rich C; Dahan R; Link J; David CS; Chou YK; Offner H; Vandenbark AA
    J Neurosci Res; 2004 Oct; 78(1):100-14. PubMed ID: 15372502
    [TBL] [Abstract][Full Text] [Related]  

  • 10. A humanized model for multiple sclerosis using HLA-DR2 and a human T-cell receptor.
    Madsen LS; Andersson EC; Jansson L; krogsgaard M; Andersen CB; Engberg J; Strominger JL; Svejgaard A; Hjorth JP; Holmdahl R; Wucherpfennig KW; Fugger L
    Nat Genet; 1999 Nov; 23(3):343-7. PubMed ID: 10610182
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Structural basis for the binding of an immunodominant peptide from myelin basic protein in different registers by two HLA-DR2 proteins.
    Li Y; Li H; Martin R; Mariuzza RA
    J Mol Biol; 2000 Nov; 304(2):177-88. PubMed ID: 11080454
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Specificity of human T cell clones reactive to immunodominant epitopes of myelin basic protein.
    Chou YK; Henderikx P; Vainiene M; Whitham R; Bourdette D; Chou CH; Hashim G; Offner H; Vandenbark AA
    J Neurosci Res; 1991 Feb; 28(2):280-90. PubMed ID: 1709690
    [TBL] [Abstract][Full Text] [Related]  

  • 13. HLA restriction and TCR usage of T lymphocytes specific for a novel candidate autoantigen, X2 MBP, in multiple sclerosis.
    Voskuhl RR; Robinson ED; Segal BM; Tranquill L; Camphausen K; Albert PS; Richert JR; McFarland HF
    J Immunol; 1994 Nov; 153(10):4834-44. PubMed ID: 7525716
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Immunity to TCR peptides in multiple sclerosis. II. T cell recognition of V beta 5.2 and V beta 6.1 CDR2 peptides.
    Chou YK; Morrison WJ; Weinberg AD; Dedrick R; Whitham R; Bourdette DN; Hashim G; Offner H; Vandenbark AA
    J Immunol; 1994 Mar; 152(5):2520-9. PubMed ID: 7510747
    [TBL] [Abstract][Full Text] [Related]  

  • 15. High affinity presentation of an autoantigenic peptide in type I diabetes by an HLA class II protein encoded in a haplotype protecting from disease.
    Bach JM; Otto H; Nepom GT; Jung G; Cohen H; Timsit J; Boitard C; van Endert PM
    J Autoimmun; 1997 Aug; 10(4):375-86. PubMed ID: 9237801
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Immunity to T cell receptor peptides in multiple sclerosis. III. Preferential immunogenicity of complementarity-determining region 2 peptides from disease-associated T cell receptor BV genes.
    Bourdette DN; Chou YK; Whitham RH; Buckner J; Kwon HJ; Nepom GT; Buenafe A; Cooper SA; Allegretta M; Hashim GA; Offner H; Vandenbark AA
    J Immunol; 1998 Jul; 161(2):1034-44. PubMed ID: 9670985
    [TBL] [Abstract][Full Text] [Related]  

  • 17. The T-cell response to myelin basic protein in familial multiple sclerosis: diversity of fine specificity, restricting elements, and T-cell receptor usage.
    Joshi N; Usuku K; Hauser SL
    Ann Neurol; 1993 Sep; 34(3):385-93. PubMed ID: 7689820
    [TBL] [Abstract][Full Text] [Related]  

  • 18. T cell response to myelin basic protein epitopes in multiple sclerosis patients and healthy subjects.
    Liblau R; Tournier-Lasserve E; Maciazek J; Dumas G; Siffert O; Hashim G; Bach MA
    Eur J Immunol; 1991 Jun; 21(6):1391-5. PubMed ID: 1710565
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Ligand motifs of HLA-DRB5*0101 and DRB1*1501 molecules delineated from self-peptides.
    Vogt AB; Kropshofer H; Kalbacher H; Kalbus M; Rammensee HG; Coligan JE; Martin R
    J Immunol; 1994 Aug; 153(4):1665-73. PubMed ID: 7519208
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Influence of HLA-DR genes on the production of rheumatoid arthritis-specific autoantibodies to citrullinated fibrinogen.
    Auger I; Sebbag M; Vincent C; Balandraud N; Guis S; Nogueira L; Svensson B; Cantagrel A; Serre G; Roudier J
    Arthritis Rheum; 2005 Nov; 52(11):3424-32. PubMed ID: 16255019
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 33.